Actionable genomic risk that fits a routine visit.

ARC-OMIX is built around your workflow. Once the tests launch, ordering will take minutes, and results will arrive with an interpretation guide written for clinicians and patient-facing materials for the visit. The ARC-PREVENT panel for proactive profiling and ARC-CHOL, for when a specific indication is in front of you, are both coming soon.

Sample report · ARC-PREVENT panel
Clipping from an ARC-OMIX ARC-PREVENT report showing polygenic risk percentiles for coronary heart disease, atrial fibrillation, abdominal aortic aneurysm, type 2 diabetes, and chronic kidney disease
A percentile for each conditionFive conditions on one page, against similarly aged adults.
Absolute risk where feasibleThe number you act on, not just a rank.
Actions at each risk tierSuggested next steps and patient talking points.

The ARC-PREVENT panel is coming soon.

Where integrated risk alters management.

Scenario 01

Borderline risk category

LDL of 140 and a Pooled Cohort Equations estimate of 6.5%, just below the 7.5% statin-discussion threshold. A top-decile CHD polygenic score from ARC-PREVENT reclassifies the patient and supports earlier statin consideration.

Above threshold7.5% thresholdPCE 6.5%Top-decile PRS reclassifies
Scenario 02

Family history

Father had an MI at 52; no severe hypercholesterolemia variant found; standard workup clean. The ARC-PREVENT CHD polygenic score further quantifies the heritable load so you can decide whether earlier screening or treatment is warranted.

Father · MI at 52Workup cleanPRS quantifies heritable load
Scenario 03

Proactive risk profiling

A motivated 45-year-old with no symptoms. The ARC-PREVENT panel returns a polygenic percentile across five conditions, and ARC-PREVENT Premium adds an absolute CHD risk estimate, letting you personalize screening intervals and counseling.

CHDT2DCKDAFibAAA

Track your order through the ARC-OMIX portal.

sample →
01
Order
ARC-OMIX portal
You
Order in the portal

Sign in to the ARC-OMIX portal, select the panel or test, and confirm. It takes a few minutes.

sequence data →
02
Sequencing
Blended genome-exome (BGE)
You
Sample collected

Saliva collection materials ship directly to the patient with a prepaid return label; or provide a requisition for a blood draw at any phlebotomy lab. No visit required.

signed report →
03
Integrated scoring
ARC-OMIX pipeline
You
Results delivered to you

Report delivered to the ordering provider via the secure portal after specimen receipt, with decision support written for clinicians.

04
Reports
Clinician and patient
You
Discuss with patient

The report includes a plain-language summary to hand to the patient and talking-point guidance for each risk tier.

Structured around how clinicians decide.

Each report answers the two questions clinicians ask: how high is this patient’s risk, and what should I do about it?

Request sample report
Percentile score for each condition
Absolute risk estimate where feasible
Suggested clinical actions at each risk tier
Cascade-testing guidance on monogenic-positive findings
Patient-facing summary suitable to hand over during the visit
References to supporting evidence for each condition
Step 1 of 4
Carries the variantTested, does not carry itBeing testedNot yet tested

Illustrative pedigree, not a real family. The arrow marks your patient. Cascade testing will be offered with ARC-CHOL to first-degree relatives of a confirmed pathogenic-variant carrier; pricing will be confirmed at launch.

With ARC-CHOL

One confirmed variant opens testing for the whole family.

When ARC-CHOL finds a pathogenic variant, the result matters beyond your patient: one confirmed variant prompts testing across first-degree relatives — parents, siblings, and children.

Patients who want to go deeper into their results can talk with you about meeting with a genetic counselor.

Clinician FAQs

For billing and order-logistics questions, see the Orders FAQ on Pricing.

How is ARC-OMIX different from other PRS testing services?+

ARC-OMIX combines clinical context with integrated genomic risk: an ancestry-calibrated polygenic risk score in every test, rare-variant classification in ARC-CHOL, and family history in ARC-PREVENT Premium. Each report shows where a score's validation is complete and where it is still in progress.

Does insurance cover the test?+

ARC-OMIX is not in-network with any payer; testing will be self-pay at launch.

How does PRS perform across ancestries?+

PRS performance varies by genetic ancestry, a legacy of Euro-centric GWAS training data. ARC-OMIX addresses this with ensemble scoring and genotype-derived ancestry calibration.

What conditions are covered?+

The ARC-PREVENT prevention panel covers five conditions — coronary heart disease, chronic kidney disease, abdominal aortic aneurysm, atrial fibrillation, and type 2 diabetes — in two tiers (Essential and Premium). ARC-CHOL, our indication-based test for severe hypercholesterolemia, launches alongside it; additional indication-based tests are in development.

What happens if a sample fails?+

We will re-run the test at no charge. If a second sample is needed, we will ship new collection materials at our expense.

How is patient data protected?+

Patient data and reports are stored in a HIPAA-compliant, encrypted environment.

How do I get added to the ordering portal?+

Create a free account in the clinician portal (arc-omix.com/orders) with your NPI. We check it against the national provider registry and email you once you're approved.

Get ready for launch.

ARC-PREVENT and ARC-CHOL launch together. Review the evidence now, and create a free clinician portal account with your NPI so you can order the day they launch.